AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. حسب Matthew Drill (22258391)

"…Scale bars = 100µm <b>(f)</b> Dose-response relationship between AZ10606120 treatments and cell number in U251 cell cultures demonstrating that increasing AZ10606120 concentrations (0-50µM) correlated to decreasing cell number. This relationship was modelled using a non-linear least squares regression model for a sigmoidal curve. …"

Association of covariates and COPD risk. حسب Yushan Shi (16440272)

الموضوعات:

Location of (A) South Sudan and (B) study counties (Maridi, Mundri East, Mundri West, Mvolo and Wulu). حسب Luís-Jorge Amaral (16406704)

الموضوعات:

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. حسب Kevin J. Johnson (2647639)

Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> proportional... حسب Teagan McMahon (20108036)

Status (A) and duration (B) of breast feeding among participants. حسب Sara Saleh (6733619)

الموضوعات:

Schema of the experimental procedure. حسب Marcel F. Hinss (14675457)

الموضوعات:

The St Mary’s Hospital Sleep Questionnaire was used to estimate the sleep quality on the previous night. حسب Marcel F. Hinss (14675457)

الموضوعات:

Examples of different stimuli for all subtasks of the task. حسب Marcel F. Hinss (14675457)

الموضوعات:

Summary of demographics: Left: Distribution of age; Right: Distribution of handedness as assessed by the EDI [40]. حسب Marcel F. Hinss (14675457)

الموضوعات:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. حسب Ningning Wang (560944)

الموضوعات:

Table_2_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.xlsx حسب Kristin R. Anderson (5478734)

Image_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.jpg حسب Kristin R. Anderson (5478734)

Table_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.pdf حسب Kristin R. Anderson (5478734)

Data sample demographics. Note that AP refers to anti-psychotic medication, and AD refers to anti-depressive medication. Thus, AP and AD in this table refer to the percentage of pa... حسب Eloy Geenjaar (21533195)

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx حسب Xuanbo Zhou (19374205)

Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> حسب Chang Seok Han (21814121)

"…In addition, genetic variation in age-related plasticity in exploration contributed to a decrease in the magnitude of genetic correlations during the adult stage. …"

Data Sheet 1_Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.pdf حسب Jingjing Fang (124938)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"